- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00961103
Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)
Assessment of Motor Development Related to Use of Orthoses in SMA II and III
Spinal Muscular Atrophy (SMA) is neurodegenerative disease of anterior horn cells of spinal cord and represents the second more frequent pathology in childhood.
According to the age of onset and the maximum motor function the disorder is classified in 4 types. Patients with SMA II and SMA III often use orthoses to achieve postural and dynamic functions.
In this retrospective observational study the investigators describe the characteristics of sitting position, standing and walking correlated to type and time of orthoses used.
Study Overview
Status
Conditions
Detailed Description
We collect data from patients with SMA II and SMA III referred to UDGEE from jan. 1995 to dec. 2008.
We estimate to achieve informations about 50-70 patients.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Manuela Lodesani, MD
- Phone Number: 5962 +390522296184
- Email: lodesani.manuela@asmn.re.it
Study Locations
-
-
RE
-
Reggio Emilia, RE, Italy, 42100
- UDGEE Hospital S.Maria Nuova
-
Contact:
- Manuela Lodesani, MD
- Phone Number: 5962 +390522296184
- Email: lodesani.manuela@asmn.re.it
-
Sub-Investigator:
- Mariacristina Filippi, PT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical and genetics diagnosis of SMA II and SMA III
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
SMA II and SMA III
patients with SMA II and SMA III
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
time and percentage of sitting, standing, walking achievement in SMA II and SMA III
Time Frame: aug.2009- nov.2009
|
aug.2009- nov.2009
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
characteristics and percentage of orthoses for postural sitting control , standing and walking in SMA II and SMA III
Time Frame: aug. 2009 - dec.2009
|
aug. 2009 - dec.2009
|
Collaborators and Investigators
Investigators
- Study Director: Adriano Ferrari, MD, Hospital S.Maria Nuova Reggio Emilia Italy
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UDGEE-SMA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Muscular Atrophy
-
Marco CapogrossoRoche-GenentechRecruitingSpinal Muscular Atrophy Type 3 | Spinal Muscular Atrophy Type 4United States
-
Institut de Myologie, FranceInstitut RocheCompletedType 2 Spinal Muscular Atrophy | Type 3 Spinal Muscular AtrophyBelgium, France, Germany
-
Marco CapogrossoRoche-GenentechNot yet recruitingSpinal Muscular Atrophy | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy 4United States
-
Novartis Gene TherapiesActive, not recruitingSMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type IIIUnited States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
-
Hoffmann-La RocheRecruitingSpinal Muscular Atrophy (SMA)Belgium, United States, Croatia, Japan, Netherlands, Spain, Canada, Poland, United Kingdom, Italy, Portugal, Australia
-
Northwell HealthCompletedAdult Spinal Muscular AtrophyUnited States
-
Hugh McMillanFamilies of Spinal Muscular Atrophy; Gwendolyn Strong FoundationTerminatedSpinal Muscular Atrophy (SMA)Canada
-
AveXis, Inc.United BioSource, LLCRecruitingSpinal Muscular Atrophy (SMA)Japan, United States, Korea, Republic of, Israel, Greece, Ireland, Portugal, Russian Federation, Taiwan
-
Hoffmann-La RocheAssociation Française contre les Myopathies (AFM), ParisCompletedSpinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III Non AmbulantGermany, Italy, France, Belgium, Poland, Netherlands, United Kingdom
-
Istanbul Medipol University HospitalIstanbul UniversityRecruitingNeuromuscular Diseases | Spinal Muscular Atrophy Type 3Turkey